dipyridamole has been researched along with Long QT Syndrome in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Long QT Syndrome: A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sheikh, KU | 1 |
| Sarfaraz, A | 1 |
| Sarfaraz, S | 1 |
| Farooq, A | 1 |
| Munawwar, R | 1 |
| Aamir, M | 1 |
1 other study available for dipyridamole and Long QT Syndrome
| Article | Year |
|---|---|
To assess the co-relation between corrected qt interval prolongation and abnormal scan during vasodilator nuclear stress test.
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Dipyridamole; Electrocardiography; Exercise | 2021 |